Cargando…
Gene Therapy Targeting Nuclear Factor-κB: Towards Clinical Application in Inflammatory Diseases and Cancer
Nuclear factor (NF)-κB is regarded as one of the most important transcription factors and plays an essential role in the transcriptional activation of pro-inflammatory cytokines, cell proliferation and survival. NF-κB can be activated via two distinct NF-κB signal transduction pathways, the so-calle...
Autores principales: | Tas, Sander W., Vervoordeldonk, Margriet J.B.M., Tak, Paul P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864453/ https://www.ncbi.nlm.nih.gov/pubmed/19519361 http://dx.doi.org/10.2174/156652309788488569 |
Ejemplares similares
-
Local treatment with the selective IκB kinase β inhibitor NEMO-binding domain peptide ameliorates synovial inflammation
por: Tas, Sander W, et al.
Publicado: (2006) -
Intra-articular gene therapy blocking NF-κB using adeno-associated virus type 5 ameliorates adjuvant arthritis in rats
por: Adriaansen, J, et al.
Publicado: (2005) -
Advancements in adeno-associated viral gene therapy approaches: exploring a new horizon
por: Aalbers, Caroline J., et al.
Publicado: (2011) -
The effects of NF-κB inhibition by a NEMO binding domain peptide in vitro and in vivo
por: Tas, SW, et al.
Publicado: (2004) -
Differential effects of T-cell specific PKC-theta inhibition or selective intra-articular NF-κB inhibition on synovial inflammation in rat adjuvant arthritis
por: Tas, SW, et al.
Publicado: (2005)